Last reviewed · How we verify
NCT06827691
Heat Therapy and Peripheral Artery Disease
NA trial testing Heat Therapy Intervention in Peripheral Arterial Disease in 70 participants. Not yet recruiting.
20 November 2027
Quick facts
| Lead sponsor | Manchester Metropolitan University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 May 2025 |
| Primary completion | 20 November 2027 |
| Estimated completion | 1 January 2028 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Heat Therapy Intervention
Conditions studied
- Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
- Cardiovascular Health — all drugs for Cardiovascular Health →
- Vascular Function — all drugs for Vascular Function →
- Intermittent Claudication — all drugs for Intermittent Claudication →
Sponsor
Manchester Metropolitan University
Who can join
18 and older, any sex, with Peripheral Arterial Disease or Cardiovascular Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06827691
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Arterial Disease
Currently open trials in the same condition.
- NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
- NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
- NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting
Other Manchester Metropolitan University trials
Trials by the same sponsor.
- NCT07535996 — IBM Dietary Surveillance Study · not yet recruiting
- NCT06624774 — Prehabilitation's Effect on Skeletal Muscle Mass in Cardiac Patients · NA · active not recruiting
- NCT05784272 — Determinants of Progression From Phase III to IV Cardiac Rehabilitation · unknown
- NCT06063733 — Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD · NA · unknown
- NCT05588479 — Pomegranate Extract and Inflammageing · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06827691 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Manchester Metropolitan University
- Last refreshed: 14 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06827691.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing